APO Research
Talk to an analyst

APO RESEARCH · REPORT

Universal Nuclease

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Universal Nuclease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

8 January 2026199 pages

Choose your research edition.

Industry ResearchUniversal Nuclease Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Universal Nuclease Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Universal Nuclease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Universal Nuclease Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Universal Nuclease Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Universal Nuclease market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Universal Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Universal Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Universal Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Universal Nuclease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Universal Nuclease include Merck, Thermo Fisher Scientific Inc., New England Biolabs, Bio-Techne Corporation, GenScript, AMSBIO, ACROBiosystems Group, Nanjing Vazyme Biotech Co., Ltd. and Sino Biological,Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Universal Nuclease market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Universal Nuclease and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Universal Nuclease sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Universal Nuclease market size, projected growth trends, production technologies, key applications, and end-use industries.

Universal Nuclease Segment by Company

Merck

Thermo Fisher Scientific Inc.

New England Biolabs

Bio-Techne Corporation

GenScript

AMSBIO

ACROBiosystems Group

Nanjing Vazyme Biotech Co., Ltd.

Sino Biological,Inc.

ProteoGenix

Novoprotein Scientific Inc.

TransGen Biotech

Enzynomics

Yisheng Biotechnology (Shanghai) Co., Ltd.

ProSpec

KACTUS

Shanghai Biyuntian Biotechnology Co., Ltd.

RayBiotech, Inc.

Wuhan Hzymes Biotechnology Co., Ltd.

Jiangsu Jinpu Nuoan Biotechnology Co., Ltd.

Universal Nuclease Segment by Type

GMP

Scientific Research

Universal Nuclease Segment by Application

Medical Biology

Laboratory

Others

Universal Nuclease Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Universal Nuclease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Universal Nuclease and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Universal Nuclease.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Universal Nuclease market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Universal Nuclease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Universal Nuclease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Universal Nuclease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Universal Nuclease Industry Trends Table 2. Universal Nuclease Industry Drivers Table 3. Universal Nuclease Industry Opportunities and Challenges Table 4. Universal Nuclease Industry Restraints Table 5. Global Universal Nuclease Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Universal Nuclease Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Universal Nuclease Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Universal Nuclease Sales Market Share by Manufacturers Table 9. Global Universal Nuclease Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Universal Nuclease Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Universal Nuclease Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Universal Nuclease Manufacturers, Product Type & Application Table 13. Global Universal Nuclease Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Universal Nuclease by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of GMP Table 17. Major Manufacturers of Scientific Research Table 18. Global Universal Nuclease Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Universal Nuclease Sales by Type (2021-2026) & (k units) Table 20. Global Universal Nuclease Sales by Type (2027-2032) & (k units) Table 21. Global Universal Nuclease Sales Market Share by Type (2021-2026) Table 22. Global Universal Nuclease Sales Market Share by Type (2027-2032) Table 23. Global Universal Nuclease Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Universal Nuclease Revenue by Type (2021-2026) & (k units) Table 25. Global Universal Nuclease Revenue by Type (2027-2032) & (k units) Table 26. Global Universal Nuclease Revenue Market Share by Type (2021-2026) Table 27. Global Universal Nuclease Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Medical Biology Table 29. Major Manufacturers of Laboratory Table 30. Major Manufacturers of Others Table 31. Global Universal Nuclease Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Universal Nuclease Sales by Application (2021-2026) & (k units) Table 33. Global Universal Nuclease Sales by Application (2027-2032) & (k units) Table 34. Global Universal Nuclease Sales Market Share by Application (2021-2026) Table 35. Global Universal Nuclease Sales Market Share by Application (2027-2032) Table 36. Global Universal Nuclease Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Universal Nuclease Revenue by Application (2021-2026) & (k units) Table 38. Global Universal Nuclease Revenue by Application (2027-2032) & (k units) Table 39. Global Universal Nuclease Revenue Market Share by Application (2021-2026) Table 40. Global Universal Nuclease Revenue Market Share by Application (2027-2032) Table 41. Global Universal Nuclease Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Universal Nuclease Sales by Region (2021-2026) & (k units) Table 43. Global Universal Nuclease Sales Market Share by Region (2021-2026) Table 44. Global Universal Nuclease Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Universal Nuclease Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Universal Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Universal Nuclease Sales by Country (2021-2026) & (k units) Table 48. North America Universal Nuclease Sales by Country (2027-2032) & (k units) Table 49. Europe Universal Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Universal Nuclease Sales by Country (2021-2026) & (k units) Table 51. Europe Universal Nuclease Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Universal Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Universal Nuclease Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Universal Nuclease Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Universal Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Universal Nuclease Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Universal Nuclease Sales by Country (2027-2032) & (k units) Table 58. Global Universal Nuclease Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Universal Nuclease Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Universal Nuclease Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Universal Nuclease Revenue Market Share by Region (2021-2026) Table 62. Global Universal Nuclease Revenue Market Share by Region (2027-2032) Table 63. Merck Company Information Table 64. Merck Business Overview Table 65. Merck Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merck Universal Nuclease Product Portfolio Table 67. Merck Recent Development Table 68. Thermo Fisher Scientific Inc. Company Information Table 69. Thermo Fisher Scientific Inc. Business Overview Table 70. Thermo Fisher Scientific Inc. Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Thermo Fisher Scientific Inc. Universal Nuclease Product Portfolio Table 72. Thermo Fisher Scientific Inc. Recent Development Table 73. New England Biolabs Company Information Table 74. New England Biolabs Business Overview Table 75. New England Biolabs Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. New England Biolabs Universal Nuclease Product Portfolio Table 77. New England Biolabs Recent Development Table 78. Bio-Techne Corporation Company Information Table 79. Bio-Techne Corporation Business Overview Table 80. Bio-Techne Corporation Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bio-Techne Corporation Universal Nuclease Product Portfolio Table 82. Bio-Techne Corporation Recent Development Table 83. GenScript Company Information Table 84. GenScript Business Overview Table 85. GenScript Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. GenScript Universal Nuclease Product Portfolio Table 87. GenScript Recent Development Table 88. AMSBIO Company Information Table 89. AMSBIO Business Overview Table 90. AMSBIO Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. AMSBIO Universal Nuclease Product Portfolio Table 92. AMSBIO Recent Development Table 93. ACROBiosystems Group Company Information Table 94. ACROBiosystems Group Business Overview Table 95. ACROBiosystems Group Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. ACROBiosystems Group Universal Nuclease Product Portfolio Table 97. ACROBiosystems Group Recent Development Table 98. Nanjing Vazyme Biotech Co., Ltd. Company Information Table 99. Nanjing Vazyme Biotech Co., Ltd. Business Overview Table 100. Nanjing Vazyme Biotech Co., Ltd. Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Nanjing Vazyme Biotech Co., Ltd. Universal Nuclease Product Portfolio Table 102. Nanjing Vazyme Biotech Co., Ltd. Recent Development Table 103. Sino Biological,Inc. Company Information Table 104. Sino Biological,Inc. Business Overview Table 105. Sino Biological,Inc. Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Sino Biological,Inc. Universal Nuclease Product Portfolio Table 107. Sino Biological,Inc. Recent Development Table 108. ProteoGenix Company Information Table 109. ProteoGenix Business Overview Table 110. ProteoGenix Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. ProteoGenix Universal Nuclease Product Portfolio Table 112. ProteoGenix Recent Development Table 113. Novoprotein Scientific Inc. Company Information Table 114. Novoprotein Scientific Inc. Business Overview Table 115. Novoprotein Scientific Inc. Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Novoprotein Scientific Inc. Universal Nuclease Product Portfolio Table 117. Novoprotein Scientific Inc. Recent Development Table 118. TransGen Biotech Company Information Table 119. TransGen Biotech Business Overview Table 120. TransGen Biotech Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. TransGen Biotech Universal Nuclease Product Portfolio Table 122. TransGen Biotech Recent Development Table 123. Enzynomics Company Information Table 124. Enzynomics Business Overview Table 125. Enzynomics Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Enzynomics Universal Nuclease Product Portfolio Table 127. Enzynomics Recent Development Table 128. Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information Table 129. Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview Table 130. Yisheng Biotechnology (Shanghai) Co., Ltd. Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Yisheng Biotechnology (Shanghai) Co., Ltd. Universal Nuclease Product Portfolio Table 132. Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Development Table 133. ProSpec Company Information Table 134. ProSpec Business Overview Table 135. ProSpec Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. ProSpec Universal Nuclease Product Portfolio Table 137. ProSpec Recent Development Table 138. KACTUS Company Information Table 139. KACTUS Business Overview Table 140. KACTUS Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. KACTUS Universal Nuclease Product Portfolio Table 142. KACTUS Recent Development Table 143. Shanghai Biyuntian Biotechnology Co., Ltd. Company Information Table 144. Shanghai Biyuntian Biotechnology Co., Ltd. Business Overview Table 145. Shanghai Biyuntian Biotechnology Co., Ltd. Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Shanghai Biyuntian Biotechnology Co., Ltd. Universal Nuclease Product Portfolio Table 147. Shanghai Biyuntian Biotechnology Co., Ltd. Recent Development Table 148. RayBiotech, Inc. Company Information Table 149. RayBiotech, Inc. Business Overview Table 150. RayBiotech, Inc. Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. RayBiotech, Inc. Universal Nuclease Product Portfolio Table 152. RayBiotech, Inc. Recent Development Table 153. Wuhan Hzymes Biotechnology Co., Ltd. Company Information Table 154. Wuhan Hzymes Biotechnology Co., Ltd. Business Overview Table 155. Wuhan Hzymes Biotechnology Co., Ltd. Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Wuhan Hzymes Biotechnology Co., Ltd. Universal Nuclease Product Portfolio Table 157. Wuhan Hzymes Biotechnology Co., Ltd. Recent Development Table 158. Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Company Information Table 159. Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Business Overview Table 160. Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Universal Nuclease Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Universal Nuclease Product Portfolio Table 162. Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Recent Development Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Universal Nuclease Distributors List Table 166. Universal Nuclease Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Universal Nuclease Product Image Figure 2. Global Universal Nuclease Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Universal Nuclease Market Size (2021-2032) & (US$ Million) Figure 4. Global Universal Nuclease Sales (2021-2032) & (k units) Figure 5. Global Universal Nuclease Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Universal Nuclease Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. GMP Image Figure 9. Scientific Research Image Figure 10. Global Universal Nuclease Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Universal Nuclease Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Universal Nuclease Sales Market Share by Type (2021-2032) Figure 13. Global Universal Nuclease Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Universal Nuclease Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Universal Nuclease Revenue Market Share by Type (2021-2032) Figure 16. Medical Biology Image Figure 17. Laboratory Image Figure 18. Others Image Figure 19. Global Universal Nuclease Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Universal Nuclease Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Universal Nuclease Sales Market Share by Application (2021-2032) Figure 22. Global Universal Nuclease Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Universal Nuclease Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Universal Nuclease Revenue Market Share by Application (2021-2032) Figure 25. North America Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Universal Nuclease Sales Market Share by Country (2021-2032) Figure 27. U.S. Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Universal Nuclease Sales Market Share by Country (2021-2032) Figure 32. Germany Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Universal Nuclease Sales Market Share by Country (2021-2032) Figure 39. China Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Universal Nuclease Sales Market Share by Country (2021-2032) Figure 47. Brazil Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Universal Nuclease Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Universal Nuclease Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Universal Nuclease Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Universal Nuclease Revenue (2021-2032) & (US$ Million) Figure 58. North America Universal Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Universal Nuclease Revenue (2021-2032) & (US$ Million) Figure 60. Europe Universal Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Universal Nuclease Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Universal Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Universal Nuclease Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Universal Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Universal Nuclease Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Universal Nuclease Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • GMP
  • Scientific Research
Applications
  • Medical Biology
  • Laboratory
  • Others
Companies covered
  • Merck
  • Thermo Fisher Scientific Inc.
  • New England Biolabs
  • Bio-Techne Corporation
  • GenScript
  • AMSBIO
  • ACROBiosystems Group
  • Nanjing Vazyme Biotech Co., Ltd.
  • Sino Biological,Inc.
  • ProteoGenix
  • Novoprotein Scientific Inc.
  • TransGen Biotech
  • Enzynomics
  • Yisheng Biotechnology (Shanghai) Co., Ltd.
  • ProSpec
  • KACTUS
  • Shanghai Biyuntian Biotechnology Co., Ltd.
  • RayBiotech, Inc.
  • Wuhan Hzymes Biotechnology Co., Ltd.
  • Jiangsu Jinpu Nuoan Biotechnology Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Universal Nuclease Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Universal Nuclease Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Universal Nuclease Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Universal Nuclease Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Universal Nuclease Market Dynamics
  1. 2.1 Universal Nuclease Industry Trends
  2. 2.2 Universal Nuclease Industry Drivers
  3. 2.3 Universal Nuclease Industry Opportunities and Challenges
  4. 2.4 Universal Nuclease Industry Restraints
3 Universal Nuclease Market by Manufacturers
  1. 3.1 Global Universal Nuclease Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Universal Nuclease Sales by Manufacturers (2021-2026)
  3. 3.3 Global Universal Nuclease Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Universal Nuclease Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Universal Nuclease Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Universal Nuclease Manufacturers, Product Type & Application
  7. 3.7 Global Universal Nuclease Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Universal Nuclease Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Universal Nuclease Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Universal Nuclease Tier 1, Tier 2, and Tier 3
4 Universal Nuclease Market by Type
  1. 4.1 Universal Nuclease Type Introduction
  2. 4.1.1 GMP
  3. 4.1.2 Scientific Research
  4. 4.2 Global Universal Nuclease Sales by Type
  5. 4.2.1 Global Universal Nuclease Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Universal Nuclease Sales by Type (2021-2032)
  7. 4.2.3 Global Universal Nuclease Sales Market Share by Type (2021-2032)
  8. 4.3 Global Universal Nuclease Revenue by Type
  9. 4.3.1 Global Universal Nuclease Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Universal Nuclease Revenue by Type (2021-2032)
  11. 4.3.3 Global Universal Nuclease Revenue Market Share by Type (2021-2032)
5 Universal Nuclease Market by Application
  1. 5.1 Universal Nuclease Application Introduction
  2. 5.1.1 Medical Biology
  3. 5.1.2 Laboratory
  4. 5.1.3 Others
  5. 5.2 Global Universal Nuclease Sales by Application
  6. 5.2.1 Global Universal Nuclease Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Universal Nuclease Sales by Application (2021-2032)
  8. 5.2.3 Global Universal Nuclease Sales Market Share by Application (2021-2032)
  9. 5.3 Global Universal Nuclease Revenue by Application
  10. 5.3.1 Global Universal Nuclease Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Universal Nuclease Revenue by Application (2021-2032)
  12. 5.3.3 Global Universal Nuclease Revenue Market Share by Application (2021-2032)
6 Global Universal Nuclease Sales by Region
  1. 6.1 Global Universal Nuclease Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Universal Nuclease Sales by Region (2021-2032)
  3. 6.2.1 Global Universal Nuclease Sales by Region (2021-2026)
  4. 6.2.2 Global Universal Nuclease Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Universal Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Universal Nuclease Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Universal Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Universal Nuclease Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Universal Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Universal Nuclease Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Universal Nuclease Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Universal Nuclease Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Universal Nuclease Revenue by Region
  1. 7.1 Global Universal Nuclease Revenue by Region
  2. 7.1.1 Global Universal Nuclease Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Universal Nuclease Revenue by Region (2021-2026)
  4. 7.1.3 Global Universal Nuclease Revenue by Region (2027-2032)
  5. 7.1.4 Global Universal Nuclease Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Universal Nuclease Revenue (2021-2032)
  8. 7.2.2 North America Universal Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Universal Nuclease Revenue (2021-2032)
  11. 7.3.2 Europe Universal Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Universal Nuclease Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Universal Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Universal Nuclease Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Universal Nuclease Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Universal Nuclease Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Thermo Fisher Scientific Inc.
  8. 8.2.1 Thermo Fisher Scientific Inc. Company Information
  9. 8.2.2 Thermo Fisher Scientific Inc. Business Overview
  10. 8.2.3 Thermo Fisher Scientific Inc. Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Inc. Universal Nuclease Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Inc. Recent Developments
  13. 8.3 New England Biolabs
  14. 8.3.1 New England Biolabs Company Information
  15. 8.3.2 New England Biolabs Business Overview
  16. 8.3.3 New England Biolabs Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 New England Biolabs Universal Nuclease Product Portfolio
  18. 8.3.5 New England Biolabs Recent Developments
  19. 8.4 Bio-Techne Corporation
  20. 8.4.1 Bio-Techne Corporation Company Information
  21. 8.4.2 Bio-Techne Corporation Business Overview
  22. 8.4.3 Bio-Techne Corporation Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bio-Techne Corporation Universal Nuclease Product Portfolio
  24. 8.4.5 Bio-Techne Corporation Recent Developments
  25. 8.5 GenScript
  26. 8.5.1 GenScript Company Information
  27. 8.5.2 GenScript Business Overview
  28. 8.5.3 GenScript Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GenScript Universal Nuclease Product Portfolio
  30. 8.5.5 GenScript Recent Developments
  31. 8.6 AMSBIO
  32. 8.6.1 AMSBIO Company Information
  33. 8.6.2 AMSBIO Business Overview
  34. 8.6.3 AMSBIO Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AMSBIO Universal Nuclease Product Portfolio
  36. 8.6.5 AMSBIO Recent Developments
  37. 8.7 ACROBiosystems Group
  38. 8.7.1 ACROBiosystems Group Company Information
  39. 8.7.2 ACROBiosystems Group Business Overview
  40. 8.7.3 ACROBiosystems Group Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 ACROBiosystems Group Universal Nuclease Product Portfolio
  42. 8.7.5 ACROBiosystems Group Recent Developments
  43. 8.8 Nanjing Vazyme Biotech Co., Ltd.
  44. 8.8.1 Nanjing Vazyme Biotech Co., Ltd. Company Information
  45. 8.8.2 Nanjing Vazyme Biotech Co., Ltd. Business Overview
  46. 8.8.3 Nanjing Vazyme Biotech Co., Ltd. Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nanjing Vazyme Biotech Co., Ltd. Universal Nuclease Product Portfolio
  48. 8.8.5 Nanjing Vazyme Biotech Co., Ltd. Recent Developments
  49. 8.9 Sino Biological,Inc.
  50. 8.9.1 Sino Biological,Inc. Company Information
  51. 8.9.2 Sino Biological,Inc. Business Overview
  52. 8.9.3 Sino Biological,Inc. Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sino Biological,Inc. Universal Nuclease Product Portfolio
  54. 8.9.5 Sino Biological,Inc. Recent Developments
  55. 8.10 ProteoGenix
  56. 8.10.1 ProteoGenix Company Information
  57. 8.10.2 ProteoGenix Business Overview
  58. 8.10.3 ProteoGenix Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ProteoGenix Universal Nuclease Product Portfolio
  60. 8.10.5 ProteoGenix Recent Developments
  61. 8.11 Novoprotein Scientific Inc.
  62. 8.11.1 Novoprotein Scientific Inc. Company Information
  63. 8.11.2 Novoprotein Scientific Inc. Business Overview
  64. 8.11.3 Novoprotein Scientific Inc. Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novoprotein Scientific Inc. Universal Nuclease Product Portfolio
  66. 8.11.5 Novoprotein Scientific Inc. Recent Developments
  67. 8.12 TransGen Biotech
  68. 8.12.1 TransGen Biotech Company Information
  69. 8.12.2 TransGen Biotech Business Overview
  70. 8.12.3 TransGen Biotech Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 TransGen Biotech Universal Nuclease Product Portfolio
  72. 8.12.5 TransGen Biotech Recent Developments
  73. 8.13 Enzynomics
  74. 8.13.1 Enzynomics Company Information
  75. 8.13.2 Enzynomics Business Overview
  76. 8.13.3 Enzynomics Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Enzynomics Universal Nuclease Product Portfolio
  78. 8.13.5 Enzynomics Recent Developments
  79. 8.14 Yisheng Biotechnology (Shanghai) Co., Ltd.
  80. 8.14.1 Yisheng Biotechnology (Shanghai) Co., Ltd. Company Information
  81. 8.14.2 Yisheng Biotechnology (Shanghai) Co., Ltd. Business Overview
  82. 8.14.3 Yisheng Biotechnology (Shanghai) Co., Ltd. Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Yisheng Biotechnology (Shanghai) Co., Ltd. Universal Nuclease Product Portfolio
  84. 8.14.5 Yisheng Biotechnology (Shanghai) Co., Ltd. Recent Developments
  85. 8.15 ProSpec
  86. 8.15.1 ProSpec Company Information
  87. 8.15.2 ProSpec Business Overview
  88. 8.15.3 ProSpec Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 ProSpec Universal Nuclease Product Portfolio
  90. 8.15.5 ProSpec Recent Developments
  91. 8.16 KACTUS
  92. 8.16.1 KACTUS Company Information
  93. 8.16.2 KACTUS Business Overview
  94. 8.16.3 KACTUS Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 KACTUS Universal Nuclease Product Portfolio
  96. 8.16.5 KACTUS Recent Developments
  97. 8.17 Shanghai Biyuntian Biotechnology Co., Ltd.
  98. 8.17.1 Shanghai Biyuntian Biotechnology Co., Ltd. Company Information
  99. 8.17.2 Shanghai Biyuntian Biotechnology Co., Ltd. Business Overview
  100. 8.17.3 Shanghai Biyuntian Biotechnology Co., Ltd. Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Shanghai Biyuntian Biotechnology Co., Ltd. Universal Nuclease Product Portfolio
  102. 8.17.5 Shanghai Biyuntian Biotechnology Co., Ltd. Recent Developments
  103. 8.18 RayBiotech, Inc.
  104. 8.18.1 RayBiotech, Inc. Company Information
  105. 8.18.2 RayBiotech, Inc. Business Overview
  106. 8.18.3 RayBiotech, Inc. Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 RayBiotech, Inc. Universal Nuclease Product Portfolio
  108. 8.18.5 RayBiotech, Inc. Recent Developments
  109. 8.19 Wuhan Hzymes Biotechnology Co., Ltd.
  110. 8.19.1 Wuhan Hzymes Biotechnology Co., Ltd. Company Information
  111. 8.19.2 Wuhan Hzymes Biotechnology Co., Ltd. Business Overview
  112. 8.19.3 Wuhan Hzymes Biotechnology Co., Ltd. Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Wuhan Hzymes Biotechnology Co., Ltd. Universal Nuclease Product Portfolio
  114. 8.19.5 Wuhan Hzymes Biotechnology Co., Ltd. Recent Developments
  115. 8.20 Jiangsu Jinpu Nuoan Biotechnology Co., Ltd.
  116. 8.20.1 Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Company Information
  117. 8.20.2 Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Business Overview
  118. 8.20.3 Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Universal Nuclease Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Universal Nuclease Product Portfolio
  120. 8.20.5 Jiangsu Jinpu Nuoan Biotechnology Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Universal Nuclease Value Chain Analysis
  2. 9.1.1 Universal Nuclease Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Universal Nuclease Production Mode & Process
  6. 9.2 Universal Nuclease Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Universal Nuclease Distributors
  9. 9.2.3 Universal Nuclease Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst